175 related articles for article (PubMed ID: 12855220)
1. Partial response to biotin therapy in a patient with holocarboxylase synthetase deficiency: clinical, biochemical, and molecular genetic aspects.
Santer R; Muhle H; Suormala T; Baumgartner ER; Duran M; Yang X; Aoki Y; Suzuki Y; Stephani U
Mol Genet Metab; 2003 Jul; 79(3):160-6. PubMed ID: 12855220
[TBL] [Abstract][Full Text] [Related]
2. Clinical findings and biochemical and molecular analysis of four patients with holocarboxylase synthetase deficiency.
Morrone A; Malvagia S; Donati MA; Funghini S; Ciani F; Pela I; Boneh A; Peters H; Pasquini E; Zammarchi E
Am J Med Genet; 2002 Jul; 111(1):10-8. PubMed ID: 12124727
[TBL] [Abstract][Full Text] [Related]
3. Holocarboxylase synthetase deficiency: report of one case.
Chou IC; Wang CS; Lin WD; Lin HC; Tsai CH; Wang TR; Tsai FJ
Acta Paediatr Taiwan; 2006; 47(6):309-11. PubMed ID: 17407983
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and molecular analysis of an atypical case of holocarboxylase synthetase deficiency.
Sakamoto O; Suzuki Y; Li X; Aoki Y; Hiratsuka M; Holme E; Kudoh J; Shimizu N; Narisawa K
Eur J Pediatr; 2000; 159(1-2):18-22. PubMed ID: 10653324
[TBL] [Abstract][Full Text] [Related]
5. Management of a patient with holocarboxylase synthetase deficiency.
Van Hove JL; Josefsberg S; Freehauf C; Thomas JA; Thuy le P; Barshop BA; Woontner M; Mock DM; Chiang PW; Spector E; Meneses-Morales I; Cervantes-Roldán R; León-Del-Río A
Mol Genet Metab; 2008 Dec; 95(4):201-5. PubMed ID: 18974016
[TBL] [Abstract][Full Text] [Related]
6. Five patients with a biotin-responsive defect in holocarboxylase formation: evaluation of responsiveness to biotin therapy in vivo and comparative biochemical studies in vitro.
Suormala T; Fowler B; Duran M; Burtscher A; Fuchshuber A; Tratzmüller R; Lenze MJ; Raab K; Baur B; Wick H; Baumgartner R
Pediatr Res; 1997 May; 41(5):666-73. PubMed ID: 9128289
[TBL] [Abstract][Full Text] [Related]
7. Lactic acidosis in biotin-responsive multiple carboxylase deficiency caused by holocarboxylase synthetase deficiency of early and late onset.
Sherwood WG; Saunders M; Robinson BH; Brewster T; Gravel RA
J Pediatr; 1982 Oct; 101(4):546-50. PubMed ID: 6811711
[TBL] [Abstract][Full Text] [Related]
8. Biotin regulates the genetic expression of holocarboxylase synthetase and mitochondrial carboxylases in rats.
Rodríguez-Meléndez R; Cano S; Méndez ST; Velázquez A
J Nutr; 2001 Jul; 131(7):1909-13. PubMed ID: 11435506
[TBL] [Abstract][Full Text] [Related]
9. Expert consensus on screening, diagnosis and treatment of multiple carboxylase deficiency.
Division of Biochemistry and Metabolism, Medical Genetics Branch, Chinese Medical Association ; Division of Genetics and Metabolism, Child Diseases and Health Care Branch, Chinese Association for Maternal and Child Health ; Division of Genetics and Metabolism, Rare Diseases Committee of Beijing Medical Association
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 51(1):129-135. PubMed ID: 35576117
[TBL] [Abstract][Full Text] [Related]
10. The first reported HLCS gene mutation causing holocarboxylase synthetase deficiency in a Vietnamese patient.
Hui J; Law E; Chung C; Fung S; Yuen P; Tang N
World J Pediatr; 2012 Aug; 8(3):278-80. PubMed ID: 21874615
[TBL] [Abstract][Full Text] [Related]
11. A genomic approach to mutation analysis of holocarboxylase synthetase gene in three Chinese patients with late-onset holocarboxylase synthetase deficiency.
Tang NL; Hui J; Yong CK; Wong LT; Applegarth DA; Vallance HD; Law LK; Fung SL; Mak TW; Sung YM; Cheung KL; Fok TF
Clin Biochem; 2003 Mar; 36(2):145-9. PubMed ID: 12633764
[TBL] [Abstract][Full Text] [Related]
12. Holocarboxylase synthetase deficiency: novel clinical and molecular findings.
Tammachote R; Janklat S; Tongkobpetch S; Suphapeetiporn K; Shotelersuk V
Clin Genet; 2010 Jul; 78(1):88-93. PubMed ID: 20095979
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the holocarboxylase synthetase gene HLCS.
Suzuki Y; Yang X; Aoki Y; Kure S; Matsubara Y
Hum Mutat; 2005 Oct; 26(4):285-90. PubMed ID: 16134170
[TBL] [Abstract][Full Text] [Related]
14. Clinical, biochemical, and genetic analysis of a Chinese Han pedigree with holocarboxylase synthetase deficiency: a case report.
Zheng Z; Yuan G; Zheng M; Lin Y; Zheng F; Jiang M; Zhu L; Fu Q
BMC Med Genet; 2020 Jul; 21(1):155. PubMed ID: 32727382
[TBL] [Abstract][Full Text] [Related]
15. [Delayed onset holocarboxylase synthetase deficiency with normal pyruvate carboxylase activity].
Vitoria I; Rausell D; González I; Pérez-Cerdá C; Dalmau J
An Pediatr (Barc); 2014 Mar; 80(3):184-6. PubMed ID: 24099927
[TBL] [Abstract][Full Text] [Related]
16. Enzyme studies in biotin-responsive disorders.
Bartlett K; Ghneim HK; Stirk HJ; Wastell H
J Inherit Metab Dis; 1985; 8 Suppl 1():46-52. PubMed ID: 2864473
[TBL] [Abstract][Full Text] [Related]
17. Holocarboxylase synthetase deficiency: early diagnosis and management of a new case.
Fuchshuber A; Suormala T; Roth B; Duran M; Michalk D; Baumgartner ER
Eur J Pediatr; 1993 May; 152(5):446-9. PubMed ID: 8319716
[TBL] [Abstract][Full Text] [Related]
18. Late-onset holocarboxylase synthetase-deficiency: pre- and post-natal diagnosis and evaluation of effectiveness of antenatal biotin therapy.
Suormala T; Fowler B; Jakobs C; Duran M; Lehnert W; Raab K; Wick H; Baumgartner ER
Eur J Pediatr; 1998 Jul; 157(7):570-5. PubMed ID: 9686819
[TBL] [Abstract][Full Text] [Related]
19. Isolated 3-methylcrotonyl-CoA carboxylase deficiency: evidence for an allele-specific dominant negative effect and responsiveness to biotin therapy.
Baumgartner MR; Dantas MF; Suormala T; Almashanu S; Giunta C; Friebel D; Gebhardt B; Fowler B; Hoffmann GF; Baumgartner ER; Valle D
Am J Hum Genet; 2004 Nov; 75(5):790-800. PubMed ID: 15359379
[TBL] [Abstract][Full Text] [Related]
20. Reduced half-life of holocarboxylase synthetase from patients with severe multiple carboxylase deficiency.
Bailey LM; Ivanov RA; Jitrapakdee S; Wilson CJ; Wallace JC; Polyak SW
Hum Mutat; 2008 Jun; 29(6):E47-57. PubMed ID: 18429047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
